Venture Capital Investors

Advent Life Sciences

Advent Life Sciences invests in innovation by backing companies focused on high-impact, technology-driven solutions.

Venture Investor Overview

Venture Investor
Advent Life Sciences
Status
Active
Investor Type
Venture Capital
Activity Level
Funds Raised
Industry Focus
Biopharmaceutical
Healthcare Services
Medical Devices & Instruments

Contact Information

Contact
Shahzad Malik
Title
General Partner
Mailing Address
158-160 North Gower St.
London, NW1 2ND
UK
Email Address

Background Information

Overview
Advent Life Sciences is one of Europe's leading venture teams investing in life sciences businesses. The team consists of 11 professionals with extensive scientific, medical and operational experience, and a long-standing track record of entrepreneurial and investment success across the UK, Europe and the US. The Firm invests in a range of sectors within life sciences, principally in new drug discovery, enabling technologies, and med tech. Realisations in the last three years include Algeta, Avila, CN Creative, EUSA, Micromet. Current investments include Acutus, Biocartis, Cellnovo, f2G, NeRRe,
Profile
Advent Life Sciences LinkedIn Company Profile
Social Media
Advent Life Sciences Company Twitter Account
Company News
Advent Life Sciences News
Facebook
Advent Life Sciences on Facebook
YouTube
Advent Life Sciences on YouTube
Last Transaction
2/27/2024

Transaction History

Our records indicate that Advent Life Sciences invested in the VC transactions listed below. Dollar amounts are for the entire raise, which may include other investors.

Company
Date
Amount
2/27/2024
$59,000,000
2/27/2024
$51,420,000
1/4/2024
$65,000,000
10/19/2022
$35,000,000
9/16/2022
$16,000,000
6/29/2022
$97,000,000
6/14/2022
$80,000,000
5/12/2022
$26,000,000
4/25/2022
$13,600,000
3/23/2021
$80,000,000
8/13/2020
$60,800,000
4/21/2020
$7,500,000
4/16/2020
$5,000,000
10/7/2019
$34,000,000
4/19/2019
$75,000,000
4/3/2018
$20,000,000
12/22/2017
$30,000,000
10/6/2017
$9,500,000
5/20/2017
$65,000,000
5/3/2017
$14,500,000
4/13/2017
$10,000,000
3/17/2017
$50,000,000
2/28/2017
$38,000,000
6/21/2016
$60,000,000
3/22/2016
$75,000,000
2/8/2016
$7,000,000
12/21/2015
$38,500,000
3/5/2015
$21,000,000

 


Investor Contacts

Title
Name
Email & Social
Partner
Naseem Amin
  Naseem Amin LinkedIn Profile  Naseem Amin Twitter Account  Naseem Amin News  Naseem Amin on Facebook
Partner
Donald Drakeman
  Donald Drakeman LinkedIn Profile  Donald Drakeman Twitter Account  Donald Drakeman News  Donald Drakeman on Facebook
General Partner
Kaasim Mahmood
  Kaasim Mahmood LinkedIn Profile  Kaasim Mahmood Twitter Account  Kaasim Mahmood News  Kaasim Mahmood on Facebook
General Partner
Shahzad Malik
  Shahzad Malik LinkedIn Profile  Shahzad Malik Twitter Account  Shahzad Malik News  Shahzad Malik on Facebook
General Partner
Raj Parekh
  Raj Parekh LinkedIn Profile  Raj Parekh Twitter Account  Raj Parekh News  Raj Parekh on Facebook
General Partner
Dale Pfost
  Dale Pfost LinkedIn Profile  Dale Pfost Twitter Account  Dale Pfost News  Dale Pfost on Facebook

 


Funds

No fund closings have been recorded for this company.

 


Portfolio Companies

Advent Life Sciences has invested in the companies below, according to our database records. If we are missing a portfolio company, please let us know.

Tech Company

 

 


 

 

Browse more venture capital investors:

Advencap | Advent Venture Partners

 

Share this article

 


About Our VC Firm Database

The venture capital investor data above is provided by VentureDeal.com, a leading supplier of venture capital funding data.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary